• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARGON MEDICAL DEVICES OPTION ELITE RETRIEVABLE VENA CAVA FILTER; OPTION ELITE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARGON MEDICAL DEVICES OPTION ELITE RETRIEVABLE VENA CAVA FILTER; OPTION ELITE Back to Search Results
Lot Number Q1122619
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pulmonary Embolism (1498); Dyspnea (1816); Vomiting (2144); Abdominal Distention (2601)
Event Date 01/13/2018
Event Type  Injury  
Event Description
Subject is a (b)(6) female with a current malignancy, breathing difficulties due to a current unilateral segmental pe, current rle in the common femoral and external iliac veins and a caval thrombosis 2-7cm caudal to the lower renal vein.She was enrolled into preserve on (b)(6) 2017 for contraindication to anticoagulation since her anticoagulation could not be initiated due to her recent postoperative state.An option¿ elite retrievable vena cava filter was placed without complication on (b)(6) 2017 and she was discharged from hospital on (b)(6) 2017.During prolonged hospitalization from (b)(6) 2018 until (b)(6) 2018, an abdominal ct on (b)(6) 2018, performed to assess new abdominal , distention, emesis, and downtrending hemoglobin, incidentally identified ¿extensive new pulmonary emboli, partially visualized, including the right lobar pulmonary arteries.¿ these new pe were identified in the context of 1) ¿new thrombus or substantial superior extension of limited previous thrombus, with new near complete filling of the intrahepatic cava extending from the ivc filter to the confluence of the hepatic veins,¿ and 2) prior to ivc filter placement the patient was noted to have tumor thrombus in the inferior vena cava +/- additional bland thrombus, and 3) progressive metastatic disease at other sites (liver, lungs, abdomen).Thus it is unknown if new pulmonary emboli represent tumor emboli or bland thrombus emboli.The date of discharge ((b)(6) 2018) was selected as the date of resolution, after the pi's review of available medical records.
 
Manufacturer Narrative
Sample is unavailable for evaluation.Without such evident to review, the complaint cannot be confirmed.If additional information is provided in the future, a follow-up report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTION ELITE RETRIEVABLE VENA CAVA FILTER
Type of Device
OPTION ELITE
Manufacturer (Section D)
ARGON MEDICAL DEVICES
1445 flat creek rd
athens TX 75751
Manufacturer Contact
elnaz rahman
1445 flat creek rd
athens, TX 75751
MDR Report Key13018015
MDR Text Key282967995
Report Number0001625425-2021-01220
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Other
Type of Report Initial
Report Date 12/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Expiration Date11/29/2019
Device Lot NumberQ1122619
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 12/03/2021
Initial Date FDA Received12/16/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-